EUVIMEDEUVIMED entdecken
Scoping ReviewÜbersichtsarbeit

Domains and outcome measures for the assessment of digital vasculopathy and Raynaud's phenomenon in adult and juvenile systemic sclerosis: a scoping literature review

Valerio Maniscalco, Natalia Vasquez-Canizares, Jennifer Lemon, Lucy Stead, Valentina Leone, Katherine Clarke, Francesco Zulian, Suzanne C Li, Marinka Twilt, Amra Adrovic, Simone Appenzeller, Edoardo Marrani und 10 weitere

Clinical and Experimental Rheumatology · 2026

DOI: 10.55563/clinexprheumatol/76mozn ↗

Kurz gefasst

Scoping Review in der Zeitschrift Clinical and Experimental Rheumatology, 2026. Verfasst von Valerio Maniscalco und 21 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, ERN-ReCONNET Center, Meyer Children's Hospital IRCCS, Florence, Italy. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Raynaud Disease, Fingers.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Juvenile systemic sclerosis (jSSc) is a rare but severe paediatric rheumatic disease associated with substantial morbidity. Digital vasculopathy is nearly universal and includes Raynaud's phenomenon (RP), digital ulcers (DU) and critical ischemia. Despite advances in adult systemic sclerosis (SSc), progress in jSSc remains limited. This scoping review aimed to identify outcome measures used to assess digital vasculopathy in SSc and jSSc to support core outcome set development for jSSc. METHODS: A scoping review was conducted following PRISMA-ScR guidelines. Medline, Embase, Web of Science, and CENTRAL were searched (1994-2024) for prospective studies reporting outcomes in digital vasculopathy domains (DU, RP, microvascular involvement, telangiectasia). RESULTS: Of 46,002 records, 108 studies were included; 105 (97.2%) involved adults only. Fifty distinct outcome measures were identified, including 35 clinician-reported outcomes (ClinROs) and 15 patient-reported outcomes (PROs). In the DU domain, 12 ClinROs and 5 PROs were identified, with ClinROs most frequently used as primary trial endpoints. In RP, 1 ClinRO and 9 PROs were identified; PROs predominated as primary outcomes. The microvascular domain included 16 ClinROs and no PROs, with instrumental measures used as primary endpoints. In telangiectasia, 6 ClinROs and 1 PRO were identified, rarely used in trials. Only three studies included paediatric patients, and no outcome measures were validated in children. CONCLUSIONS: Outcome measures for digital vasculopathy in SSc are heterogeneous and derived almost entirely from adult studies, with no paediatric-specific validation. Transferability of these measures to children requires formal evaluation. These findings support the need for standardised, validated outcomes for jSSc and inform core outcome set development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicRaynaud DiseaseFingersHumansAdultChildAdolescentPatient Reported Outcome MeasuresFemale

Autor:innen und Institutionen

  • Rheumatology Unit, ERN-ReCONNET Center, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Department of Pediatrics, Division of Pediatric Rheumatology, Children's Hospital at Montefiore/Albert Einstein College of Medicine, Bronx, NY, USA.
  • Department of Development Paediatrics, Alder Hey Children's NHS Foundation Trust, Eaton Road, Liverpool, UK.
  • Department of Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Department of Paediatrics, Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione-IRCCS ISMETT, University of Pittsburgh Medical Centre (UPMC), Palermo, Italy.
  • Division of Paediatric Rheumatology, Department of Women and Children Health, University of Padova, Italy.

Zitieren

APA

Maniscalco, V., Vasquez-Canizares, N., Lemon, J., Stead, L., Leone, V., Clarke, K., Zulian, F., Li, S. C., Twilt, M., Adrovic, A., Appenzeller, S., Marrani, E., Çakan, M., Del Giudice, E., Cattalini, M., Tirelli, F., Robinson, L. A., Sampath, S., Mastrangelo, G., …, & International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative, and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scleroderma W… (2026). Domains and outcome measures for the assessment of digital vasculopathy and Raynaud's phenomenon in adult and juvenile systemic sclerosis: a scoping literature review. Clinical and Experimental Rheumatology. https://doi.org/10.55563/clinexprheumatol/76mozn

Vancouver

Maniscalco V, Vasquez-Canizares N, Lemon J, Stead L, Leone V, Clarke K, et al. Domains and outcome measures for the assessment of digital vasculopathy and Raynaud's phenomenon in adult and juvenile systemic sclerosis: a scoping literature review. Clinical and Experimental Rheumatology. 2026. doi:10.55563/clinexprheumatol/76mozn

BibTeX
@article{Maniscalco2026,
  author = {Maniscalco, Valerio and Vasquez-Canizares, Natalia and Lemon, Jennifer and Stead, Lucy and Leone, Valentina and Clarke, Katherine and Zulian, Francesco and Li, Suzanne C and Twilt, Marinka and Adrovic, Amra and Appenzeller, Simone and Marrani, Edoardo and Çakan, Mustafa and Del Giudice, Emanuela and Cattalini, Marco and Tirelli, Francesca and Robinson, Lauren A and Sampath, Sunil and Mastrangelo, Greta and Simonini, Gabriele and Pain, Clare E and International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative, and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scleroderma W…, International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative, and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scleroderma W…},
  title = {Domains and outcome measures for the assessment of digital vasculopathy and Raynaud's phenomenon in adult and juvenile systemic sclerosis: a scoping literature review},
  journal = {Clinical and Experimental Rheumatology},
  year = {2026},
  doi = {10.55563/clinexprheumatol/76mozn}
}
Kostenlos starten →